Strides Pharma gets USFDA nod for antidepressant medication
Strides Pharma Science, in a stock exchange filing on April 6, disclosed the outcomes of a routine inspection conducted by the United States Food and Drug Administration (USFDA) at the Formulations Facility of its wholly owned subsidiary, Strides Alathur Private Limited, situated in Chennai's Alathur.
Strides receives USFDA approval for Gabapentin
Intimation under Regulation 30 of SEBI LODR – Update on divestment of Eris Pharma GmbH, Germany
Enforcement Report - Week of January 31, 2024
Appointment of Mr. Ameet P Hariani as Independent Director of the Company
Strides reports strong Q3FY24 Revenue and EBITDA
Strides Pharma`s Generic Pregabalin Receives Approval in the U.S.
Strides Pharma Science has received an approval for investment in the securities of AMP Energy C&I Six (AMP-6) and AMP Energy C&I Eight (AMP-8). The Management Committee of the Board of Directors of the Company in its meeting held on January 2, 2024, has approved the same.
Trinity Pharma Proprietary Limited (Trinity), a step-down subsidiary of Strides Pharma Science Limited in South Africa, has availed credit facility from Investec for Business, a division of Investec Bank Limited, South Africa, for their working capital requirements of Rs. 31.5 crore.